Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03918486 · ClinicalTrials.gov registry record
Caretaker vs. Routine Blood Pressure Sphygmomanometer
A clinical trial of Blood Pressure, sponsored by The Cooper Health System.
- Completed
- Registry status
- 170
- Enrollment target
- 1
- Study location
NCT03918486 is a study of Blood Pressure that has completed, run by The Cooper Health System. The registered enrollment target is 170 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03918486, a study of Blood Pressure, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
Caretaker vs. routine blood pressure sphygmomanometer
Conditions Studied
Interventions
- DEVICE Caretaker
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2021-11-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03918486
The ClinicalTrials.gov registry entry for NCT03918486 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (40% lower). The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Caretaker is the first listed.
NCT03918486 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03918486 about?
NCT03918486 is a clinical study titled "Caretaker vs. Routine Blood Pressure Sphygmomanometer". Caretaker vs. routine blood pressure sphygmomanometer
What is the current status of trial NCT03918486?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2017-09-05. Estimated completion is 2021-11-10.
What conditions does trial NCT03918486 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT03918486?
The interventions under investigation include: Caretaker (DEVICE).
Who is sponsoring clinical trial NCT03918486?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03918486 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
RECRUITING
-
The GUARDIAN Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.